Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy

Purpose. To study the change of concentrations of vascular endothelial growth factor (VEGF) in vitreous cavity after vitrectomy in eyes with proliferative diabetic retinopathy (PDR). Methods. In this retrospective study, intravitreal fluid samples were taken at baseline (beginning of the vitrectomy)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui-Jin Chen, Zhi-Zhong Ma, Ying Li, Chang-Guan Wang
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2019/6764932
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
by: Wei Xu, et al.
Published: (2019-01-01)

A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy
by: Xiaochun Yang, et al.
Published: (2016-01-01)

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
by: Jianbo He, et al.
Published: (2015-01-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy
by: Byung Ju Jung, et al.
Published: (2019-01-01)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)

Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy
by: Robert Rejdak, et al.
Published: (2017-01-01)

Causes and Clinical Impact of Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy
by: Hazem Abdelmotaal, et al.
Published: (2020-01-01)

Unintentional Retinal Displacement in Eyes Treated for Rhegmatogenous Retinal Detachment Complicated by Proliferative Vitreoretinopathy with Pars Plana Vitrectomy and Silicone Oil
by: Mariaelena Filippelli, et al.
Published: (2021-01-01)

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
by: Satu Vavuli, et al.
Published: (2016-01-01)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
by: Ahmed M. Abu El-Asrar, et al.
Published: (2012-01-01)

Proliferative Diabetic Retinopathy and Hemovitreous: Red Flag for Blindness
by: Jaume Català, et al.
Published: (2008-01-01)

Searching for Biomarkers in Proliferative Diabetic Retinopathy: Amphiregulin and Progranulin
by: Burak BILGIN, et al.
Published: (2022-12-01)

Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients
by: Vibha Tandon, et al.
Published: (2017-01-01)

First Reported Case of Proliferative Retinopathy in Hemoglobin SE Disease
by: Paul Baciu, et al.
Published: (2014-01-01)

Causality of Blood Metabolites on Proliferative Diabetic Retinopathy: Insights From a Genetic Perspective
by: Zhaoxiang Wang, et al.
Published: (2024-01-01)

Inhibition of Endothelial Cell Tube Formation by Anti-Vascular Endothelial Growth Factor/Anti-Angiopoietin-2 RNA Nanoparticles
by: Cheng Zhong, et al.
Published: (2025-01-01)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
by: Toshiaki Kubota, et al.
Published: (2012-01-01)

Comparison between Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Levels in Rhegmatogenous Retinal Detachment
by: Andi Muhammad Ichsan, et al.
Published: (2021-01-01)

Pronerve Growth Factor Induces Angiogenesis via Activation of TrkA: Possible Role in Proliferative Diabetic Retinopathy
by: Sally L. Elshaer, et al.
Published: (2013-01-01)

Associations between Vascular Endothelial Growth Factor Gene Polymorphisms and Different Types of Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis
by: Liming Hu, et al.
Published: (2021-01-01)

Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
by: Francesco Morescalchi, et al.
Published: (2013-01-01)

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
by: Chen Zou, et al.
Published: (2018-01-01)

The Clinical Impact of Vascular Endothelial Growth Factor/Receptor (VEGF/R) Inhibitors on Voice
by: Christina Hui Lee Ng, et al.
Published: (2023-01-01)

Three Cases of Organized Hematoma of the Maxillary Sinus: Clinical Features and Immunohistological Studies for Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 Expressions
by: Shoichiro Imayoshi, et al.
Published: (2015-01-01)

Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis
by: Anikó Rentka, et al.
Published: (2015-01-01)

The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
by: Emma Roberts, et al.
Published: (2013-01-01)

25-Gauge Vitrectomy in Open Eye Injury with Retained Foreign Body
by: G. Sborgia, et al.
Published: (2017-01-01)

Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
by: Ya-Jui Hsu, et al.
Published: (2014-01-01)

Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment
by: Samir El Baha, et al.
Published: (2021-01-01)

Obstructive Sleep Apnea Monocytes Exhibit High Levels of Vascular Endothelial Growth Factor Secretion, Augmenting Tumor Progression
by: Carolina Cubillos-Zapata, et al.
Published: (2018-01-01)

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
by: Haitao Zhang, et al.
Published: (2022-01-01)

Outcomes of Vitrectomy Combined with Scleral Buckling for Eyes with Early Recurrence of Simple Rhegmatogenous Retinal Detachment Previously Treated by Pars Plana Vitrectomy
by: Tomoaki Tatsumi, et al.
Published: (2020-01-01)

Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?
by: Cristina Maria Failla, et al.
Published: (2024-12-01)

Sickle Cell Trait Presenting as Unilateral Proliferative Retinopathy and Macular Thinning in a Pregnant Woman
by: Sepideh Ghods, et al.
Published: (2021-01-01)

Serum levels of tumor necrosis factor-alpha and vascular endothelial growth factor as markers of disease activity in patients with axial spondyloarthritis
by: Mahendran Bhuvanesh, et al.
Published: (2018-01-01)

The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
by: Kailash Singh, et al.
Published: (2017-01-01)

Tonic Pupil Following Pars Plana Vitrectomy and Endolaser
by: Benyamin Ebrahim, et al.
Published: (2009-01-01)

CCAAT/Enhancer-Binding Protein β Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor
by: Tingting Li, et al.
Published: (2020-01-01)

Automated and Reproducible Detection of Vascular Endothelial Growth Factor (VEGF) in Renal Tissue Sections
by: Nayana Damiani Macedo, et al.
Published: (2019-01-01)